Source author record

Andrew D. McNaughton

Andrew D. McNaughton appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Machine Learning Biomolecules

Catalog footprint

What is connected

2works

2topics

4close collaborators

Actions

Connect this record

Open graph Browse works

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

preprint2024arXiv

Scaffold-Based Multi-Objective Drug Candidate Optimization

In therapeutic design, balancing various physiochemical properties is crucial for molecule development, similar to how Multiparameter Optimization (MPO) evaluates multiple variables to meet a primary goal. While many molecular features can now be predicted using \textit{in silico} methods, aiding early drug development, the vast data generated from high throughput virtual screening challenges the practicality of traditional MPO approaches. Addressing this, we introduce a scaffold focused graph-based Markov chain Monte Carlo framework (ScaMARS) built to generate molecules with optimal properties. This innovative framework is capable of self-training and handling a wider array of properties, sampling different chemical spaces according to the starting scaffold. The benchmark analysis on several properties shows that ScaMARS has a diversity score of 84.6\% and has a much higher success rate of 99.5\% compared to conditional models. The integration of new features into MPO significantly enhances its adaptability and effectiveness in therapeutic design, facilitating the discovery of candidates that efficiently optimize multiple properties.

preprint2022arXiv

De novo design of protein target specific scaffold-based Inhibitors via Reinforcement Learning

Efficient design and discovery of target-driven molecules is a critical step in facilitating lead optimization in drug discovery. Current approaches to develop molecules for a target protein are intuition-driven, hampered by slow iterative design-test cycles due to computational challenges in utilizing 3D structural data, and ultimately limited by the expertise of the chemist - leading to bottlenecks in molecular design. In this contribution, we propose a novel framework, called 3D-MolGNN$_{RL}$, coupling reinforcement learning (RL) to a deep generative model based on 3D-Scaffold to generate target candidates specific to a protein building up atom by atom from the starting core scaffold. 3D-MolGNN$_{RL}$ provides an efficient way to optimize key features by multi-objective reward function within a protein pocket using parallel graph neural network models. The agent learns to build molecules in 3D space while optimizing the activity, binding affinity, potency, and synthetic accessibility of the candidates generated for infectious disease protein targets. Our approach can serve as an interpretable artificial intelligence (AI) tool for lead optimization with optimized activity, potency, and biophysical properties.